|
Name |
pericinone B
|
| Molecular Formula | C33H52O3 | |
| IUPAC Name* |
15-hydroxy-4,4,10,13,14-pentamethyl-17-(6-methylhept-5-en-2-yl)-12-prop-1-en-2-yloxy-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
|
|
| SMILES |
C=C(C)OC1CC2=C(CCC3C(C)(C)C(=O)CCC23C)C2(C)C(O)CC(C(C)CCC=C(C)C)C12C
|
|
| InChI |
InChI=1S/C33H52O3/c1-20(2)12-11-13-22(5)24-18-28(35)32(9)23-14-15-26-30(6,7)27(34)16-17-31(26,8)25(23)19-29(33(24,32)10)36-21(3)4/h12,22,24,26,28-29,35H,3,11,13-19H2,1-2,4-10H3/t22-,24-,26+,28+,29-,31-,32-,33+/m1/s1
|
|
| InChIKey |
MAAAWZNOHIQQBL-MDKASVQWSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 496.78 | ALogp: | 8.2 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 46.5 | Aromatic Rings: | 4 |
| Heavy Atoms: | 36 | QED Weighted: | 0.281 |
| Caco-2 Permeability: | -4.904 | MDCK Permeability: | 0.00000947 |
| Pgp-inhibitor: | 0.129 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.025 | 20% Bioavailability (F20%): | 0.907 |
| 30% Bioavailability (F30%): | 0.966 |
| Blood-Brain-Barrier Penetration (BBB): | 0.977 | Plasma Protein Binding (PPB): | 96.44% |
| Volume Distribution (VD): | 1.778 | Fu: | 2.61% |
| CYP1A2-inhibitor: | 0.018 | CYP1A2-substrate: | 0.494 |
| CYP2C19-inhibitor: | 0.087 | CYP2C19-substrate: | 0.973 |
| CYP2C9-inhibitor: | 0.18 | CYP2C9-substrate: | 0.898 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.513 |
| CYP3A4-inhibitor: | 0.535 | CYP3A4-substrate: | 0.627 |
| Clearance (CL): | 17.642 | Half-life (T1/2): | 0.02 |
| hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.415 |
| Drug-inuced Liver Injury (DILI): | 0.049 | AMES Toxicity: | 0.015 |
| Rat Oral Acute Toxicity: | 0.131 | Maximum Recommended Daily Dose: | 0.597 |
| Skin Sensitization: | 0.039 | Carcinogencity: | 0.105 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.173 |
| Respiratory Toxicity: | 0.929 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC006068 | ![]() |
0.804 | D0X7XG | ![]() |
0.300 | ||
| ENC002119 | ![]() |
0.528 | D0H2MO | ![]() |
0.291 | ||
| ENC002075 | ![]() |
0.411 | D0T2PL | ![]() |
0.254 | ||
| ENC001582 | ![]() |
0.354 | D08SVH | ![]() |
0.254 | ||
| ENC003486 | ![]() |
0.338 | D0K5WS | ![]() |
0.252 | ||
| ENC001119 | ![]() |
0.338 | D06IIB | ![]() |
0.250 | ||
| ENC003755 | ![]() |
0.338 | D02VPX | ![]() |
0.248 | ||
| ENC003485 | ![]() |
0.329 | D02ZGI | ![]() |
0.245 | ||
| ENC002152 | ![]() |
0.319 | D0Y7LD | ![]() |
0.243 | ||
| ENC002718 | ![]() |
0.319 | D04SFH | ![]() |
0.242 | ||